XIAP and nasopharyngeal carcinoma: For instance, circ-VMA21 was demonstrated to mitigate proinflammatory cytokine–induced NPC apoptosis and ECM degradation by suppressing the miR-200c-XIAP signaling pathway (Cheng et al., 2018).